FDA Adverse Event Injury Summary report: N

XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM

MDR report key: 1200665 · Received October 17, 2008

Report

Report Number
2024168-2008-00979
Event Type
Injury
Date Received
October 17, 2008
Date of Event
May 6, 2008
Report Date
September 24, 2008
Manufacturer
ABBOTT VASCULAR-CARDIAC THERAPIES
Product Code
NIQ
PMA / PMN Number
P070015
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

RESULTS AND CONCLUSION SUMMATION: PRODUCT PERFORMANCE ENGINEERING REVIEWED THE INCIDENT INFORMATION. RESTENOSIS, AS LISTED IN THE XIENCE INSTRUCTIONS FOR USE (IFU), IS A KNOWN RISK ASSOCIATED WITH CORONARY STENTING AN IS NOT NECESSARILY AN INDICATION OF A PRODUCT QUALITY ISSUE. THERE WAS NO REPORT OF ANY DEVICE MALFUNCTION AT THE TIME OF STENT IMPLANT AND THE PROCEDURE WAS COMPLETED SUCCESSFULLY. IN THIS CASE, IT IS LIKELY THAT THE HOSPITALIZATION IS A SECONDARY EFFECT OF THE RESTENOSIS. HOWEVER, A CONCLUSIVE ROOT CAUSE FOR THE REPORTED PATIENT EFFECTS, AND THE RELATIONSHIP TO THE DEVICE, IF ANY, CANNOT BE DETERMINED.

Description of Event or Problem · 1

REPORTING STATUS: SERIOUS INJURY - MEDICAL INTERVENTION. REPORTING RATIONALE: RESTENOSIS REQUIRING MEDICAL INTERVENTION TO PREVENT PERMANENT IMPAIRMENT OR INJURY. DEVICE ISSUE: NO DEVICE MALFUNCTION HAS BEEN REPORTED. IT WAS REPORTED THAT THE INDEX PROCEDURE WAS PERFORMED IN 2007. THE 3.5 X 23 CM XIENCE V STENT WAS DEPLOYED IN THE PROXIMAL CIRCUMFLEX. THE PROCEDURE WAS SUCCESSFUL AND THERE WERE NO REPORTED PATIENT EFFECTS OR PRODUCT ISSUES. IN 2008, THE PATIENT PRESENTED WITH RESTENOSIS IN THE PROXIMAL CIRCUMFLEX, WHICH REQUIRED TREATMENT WITH A DRUG ELUTING STENT. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM NIQ ABBOTT VASCULAR-CARDIAC THERAPIES NA UNK

Patients

Seq Age Sex Outcome Treatment
1 67 YR Hospitalization| R